Molecular Oncology

Once therapeutic intervention has begun, these tests will be used to monitor patients’ responses to treatment to detect early recurrence of the disease. Similar to the screening tests described previously, the monitoring tests will be based upon tumor-specific proteins that are secreted into the blood and can be detected using standard immunodiagnostic tests.

Breast Cancer Monitoring Program

We will utilize cancer markers discovered through our breast cancer screening program to develop a blood-based breast cancer monitoring test for the detection of early recurrence. The goal of our breast cancer monitoring program is to clinically validate the cancer markers discovered for the breast screening panel to detect proteins specific for early stage breast cancer recurrence in asymptomatic patients.